Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/016580 stock hub

KRX/016580 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/016580is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

208.5B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/016580

In the news

Latest news · KRX/016580

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.8

P25 9.8P50 17.1P75 31.9

Trailing P/E13.2

P25 12P50 23.1P75 39.5

ROE3.4

P25 -17.1P50 0.7P75 8.5

ROIC3.4

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/016580 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

KRW

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	601
Enterprise value	KRW 145.5B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7016580003
Last refreshed	2026-05-10
Market cap	KRW 208.5B
Price	KRW 11,280
Price currency	KRW
Rev Per Employee	424,649,554.64x
Sector	Healthcare
Sic	2834
Symbol	krx/016580
Website	https://www.whanin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.52%
EV Earnings	10.7x
EV/EBIT	11.35x
EV/EBITDA	6.41x
EV/FCF	23.49x
EV/Sales	0.57x
FCF yield	2.97%
Forward P/E	9.83x
P/B ratio	0.5x
P/E ratio	13.16x
P/S ratio	0.82x
PE Ratio10 Y	9.93x
PE Ratio3 Y	9.03x
PE Ratio5 Y	9.75x
PEG ratio	0.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.1%
EBITDA Margin	8.97%
FCF margin	2.43%
Gross margin	33.86%
Gross Profit	KRW 86.4B
Gross Profit Growth	-7.75%
Gross Profit Growth Q	11.05%
Gross Profit Growth3 Y	-4.32%
Gross Profit Growth5 Y	-0.02%
Net Income	KRW 13.6B
Net Income Growth	-41.85%
Net Income Growth Q	-43.87%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-17.17%
Net Income Growth5 Y	-10.28%
Pretax Margin	5.85%
Profit Margin	5.33%
Profit Per Employee	KRW 22.6M
Profitable Years	19
ROA	1.8
Roa5y	4.17
ROCE	3.08
ROE	3.41
Roe5y	6.86
ROIC	3.42
Roic5y	8.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.24%
Cagr15y	5.53%
Cagr1y	-0.95%
Cagr20y	5.48%
Cagr3y	-9.32%
Cagr5y	-9.58%
Div CAGR10	1.84%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-44.01
EPS Growth Q	-48.76
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-18.21
EPS Growth5 Y	-10.96
FCF Growth Q	35.6%
FCF Growth5 Y	-15.95%
OCF Growth	-56.3%
OCF Growth Q	-34.59%
OCF Growth3 Y	-18.73%
OCF Growth5 Y	-16.85%
Revenue Growth	-1.69x
Revenue Growth Q	-1.67x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	8.66x
Revenue Growth5 Y	8.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.56
Assets	KRW 478.9B
Cash	KRW 63.7B
Current Assets	KRW 228.3B
Current Liabilities	KRW 56.5B
Debt	KRW 679M
Debt EBITDA	KRW 0.03
Debt Equity	KRW 0
Debt FCF	KRW 0.11
Equity	KRW 421B
Interest Coverage	452.5
Liabilities	KRW 57.9B
Long Term Assets	KRW 250.6B
Long Term Liabilities	KRW 1.4B
Net Cash	KRW 63B
Net Cash By Market Cap	KRW 30.24
Net Cash Growth	20.84%
Net Debt EBITDA	KRW -2.75
Net Debt Equity	KRW -0.15
Net Debt FCF	KRW -10.18
Tangible Book Value	KRW 411.7B
Tangible Book Value Per Share	KRW 22,274
WACC	5.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.04
Inventory Turnover	2
Net Working Capital	KRW 108.4B
Quick ratio	2.3
Working Capital	KRW 171.8B
Working Capital Turnover	KRW 1.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.86%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 300
Dividend Years	29
Dividend Yield	2.66%
Ex Div Date	2025-12-29
Last Dividend	KRW 300
Payout Frequency	Annual
Payout Ratio	33.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-11.71%
1Y total return	-0.95%
200-day SMA	11,076.8
3Y total return	-25.44%
50-day SMA	10,630.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.56%
All Time High	29,000
All Time High Change	-61.1%
All Time High Date	2018-02-12
All Time Low	1,257.6
All Time Low Change	796.92%
All Time Low Date	2004-05-26
ATR	320.7
Beta	0.26
Beta1y	0.16
Beta2y	0.2
Ch YTD	-0.35
High	11,600
High52	13,210
High52 Date	2025-07-11
High52ch	-14.61%
Low	11,250
Low52	9,990
Low52 Date	2026-03-09
Low52ch	12.91%
Ma50ch	6.11%
Price vs 200-day SMA	1.83%
RSI	56.29
RSI Monthly	43.38
RSI Weekly	55.48
Sharpe ratio	-0.09x
Sortino ratio	0.13
Total Return	-1.2%
Tr YTD	-0.35
Tr15y	124.26%
Tr1m	10.05%
Tr1w	-5.45%
Tr3m	9.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 13B
Operating Income Growth	-39.44
Operating Income Growth Q	62.4
Operating Income Growth3 Y	-24.13
Operating Income Growth5 Y	-14.46
Operating margin	5.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,154,489%
Net Borrowing	-539,917,330
Shares Insiders	23.42%
Shares Institutions	12.46%
Shares Out	18,483,950
Shares Qo Q	3.08%
Shares Yo Y	3.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 6.2B
Average Volume	77,499.75x
Bv Per Share	22,776.9
CAPEX	KRW -2.9B
Ch10y	-26.99
Ch15y	64.43
Ch1m	10.05
Ch1w	-5.45
Ch1y	-3.51
Ch20y	81.94
Ch3m	9.41
Ch3y	-30.58
Ch5y	-45.64
Ch6m	-2.34
Change	-1.74%
Change From Open	-0.7
Close	11,480
Days Gap	-1.05
Depreciation Amortization	9,864,829,440
Dollar Volume	774,597,600
Earnings Date	2026-05-15
EBIT	KRW 13B
EBITDA	KRW 22.9B
EPS	KRW 857
F Score	3
FCF	KRW 6.2B
FCF EV Yield	4.26x
FCF Per Share	KRW 335
Financing CF	6,583,791,460
Fiscal Year End	December
Founded	1,978
Graham Number	20961.95509
Graham Upside	85.83
Income Tax	KRW 1.3B
Investing CF	4,747,118,400
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Last Split Date	2010-04-14
Last Split Type	Forward
Lynch Fair Value	KRW 4,287
Lynch Upside	-61.99
Ma150	10,927.3
Ma150ch	3.23%
Ma20	10,999
Ma20ch	2.55%
Net CF	20,432,677,140
Next Earnings Date	2026-05-15
Open	11,360
P FCF Ratio	33.66
P OCF Ratio	23.05
Payment Date	2026-04-15
Position In Range	8.57
Ppne	144,059,381,630
Price Date	2026-05-08
Price EBITDA	KRW 9.11
Ptbv Ratio	0.51
Relative Volume	0.91x
Revenue	255,214,382,340x
Tax By Revenue	0.52x
Tax Rate	8.92%
Tr20y	190.58%
Tr6m	0.26%
Volume	68,670
Z Score	3.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/016580 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$300 annual per share

Payout ratio

+33.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

-1.2%

Next ex-dividend date: 2025-12-29

Performance

KRX/016580 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/016580?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.5%

Share of float held by funds and institutions

Insider ownership

+23.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.9%

Negative means the company is buying back shares.

Technical

KRX/016580 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.3

Neutral momentum band

Price vs 200-day MA

+1.8%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

-0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/016580

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/016580 stock rating?

krx/016580 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/016580 analysis?

The full report lives at /stocks/krx/016580/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/016580?

The latest report frames krx/016580 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/016580 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.